Johnson & Johnson (JNJ)

130.27
1.10 0.88
NYSE : Health Technology
Prev Close 129.14
Open 132.05
Day Low/High 129.20 / 132.80
52 Wk Low/High 118.62 / 148.99
Volume 17.45M
Avg Volume 7.92M
Exchange NYSE
Shares Outstanding 2.68B
Market Cap 396.50B
EPS 0.50
P/E Ratio 225.42
Div & Yield 3.60 (2.39%)

Latest News

Jim's Daily Rundown

Jim discusses his thoughts on if a 'Santa-Clause' rally is possible, tomorrow's Fed announcement, yesterday's interview with JNJ CEO Alex Gorsky on 'Mad Money', and much more!

Jim Cramer: Playing the Markets, Oracle, Johnson & Johnson

Jim Cramer: Playing the Markets, Oracle, Johnson & Johnson

Jim Cramer breaks down Real Money's stock of the day, Oracle, and his interview with Johnson & Johnson's CEO.

Federal Reserve, Oracle, T-Mobile, Les Moonves and J&J - 5 Things You Must Know

Federal Reserve, Oracle, T-Mobile, Les Moonves and J&J - 5 Things You Must Know

U.S. stock futures rise on Tuesday, rebounding slightly from Monday's sharp selloff; global shares sink in the face of slowing economic growth; Oracle spikes after earnings and revenue top analysts' forecasts; T-Mobile and Sprint merger moves another step closer to completion.

Waiting for the Fed: Cramer's 'Mad Money' Recap (Monday 12/17/18)

Waiting for the Fed: Cramer's 'Mad Money' Recap (Monday 12/17/18)

Jim Cramer says the market won't be able to find a bottom until several key conditions are met, most notably what the Fed is going to do.

Peeling Back the Band-Aid: Johnson & Johnson

Peeling Back the Band-Aid: Johnson & Johnson

Here's what you should know about the band-aid company.

Are Algos Jumping on J&J Headlines?

Are Algos Jumping on J&J Headlines?

Are machines jumping on Johnson & Johnson's human risk headlines?

Johnson & Johnson Reaffirms Guidance, Sets $5 Billion Stock Buyback

Johnson & Johnson Reaffirms Guidance, Sets $5 Billion Stock Buyback

Johnson & Johnson board sees opportunity in shares beaten down after reports the company covered up knowledge of asbestos in its talcum powder products.

Chart of the Day: Johnson & Johnson's Punishment Appears Overdone

Chart of the Day: Johnson & Johnson's Punishment Appears Overdone

Putting J&J stock's selloff in a graphic illustrates the market's swift and violent reaction to the Reuters report.

Monday Madness: Johnson & Johnson Is Still Making Headlines

Monday Madness: Johnson & Johnson Is Still Making Headlines

Johnson & Johnson, Goldman Sachs and Jack in the Box are some of the top stories on TheStreet.

Market Oversold? Dow Jones Down 500 Points, J&J Sliding More

Market Oversold? Dow Jones Down 500 Points, J&J Sliding More

There are two sides to every coin. Is the market oversold? One of TheStreet's top editors tells investors how to think.

Are Algos Jumping on J&J Headlines?

Are Algos Jumping on J&J Headlines?

Are machines jumping on Johnson & Johnson's human risk headlines?

Dow Plunges, Nasdaq Slides as December Worsens, Bear Market Looms

Dow Plunges, Nasdaq Slides as December Worsens, Bear Market Looms

Stocks fall sharply Monday as investors remain cautious over the health of the world economy.

Johnson & Johnson Announces $5 Billion Share Repurchase Program

Johnson & Johnson Announces $5 Billion Share Repurchase Program

NEW BRUNSWICK, N.J.

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Johnson & Johnson Challenges Reuters' Assertions About Its Product Safety

Shares continue to fall on Monday after Friday's swift descent.

Jim Cramer on When Johnson & Johnson Is a Buy

Jim Cramer on When Johnson & Johnson Is a Buy

Jim Cramer breaks down how investors should be looking at Johnson & Johnson.

Let's Get Real About Johnson & Johnson's Selloff and How to Play the Stock

Let's Get Real About Johnson & Johnson's Selloff and How to Play the Stock

I find a lot of Reuters' claims hard to believe. Even more difficult to believe is the selloff.

Video: Jim's Daily Rundown for Monday

Jim discusses Johnson & Johnson, Goldman Sachs, CVS Health and more!

Johnson & Johnson Stock Presents a Buying Opportunity Amid an Overblown Selloff

Johnson & Johnson Stock Presents a Buying Opportunity Amid an Overblown Selloff

Many analysts advise buying the shares on weakness because it's attractively priced.

Johnson & Johnson - Round 2 - More Selling Pressure

Johnson & Johnson - Round 2 - More Selling Pressure

JNJ ended the day and week in a vulnerable position and we are seeing further weakness today.

Jim Cramer on Johnson & Johnson, the Santa Claus Rally and the State of Gold

Jim Cramer on Johnson & Johnson, the Santa Claus Rally and the State of Gold

Jim Cramer breaks down what you need to know about the markets as Monday trading kicks off.

A Johnson & Johnson Equity Stake Is Out of the Question Right Now

A Johnson & Johnson Equity Stake Is Out of the Question Right Now

A trader can not risk buying the name here outright unless one is certain on a lot of items that are currently unknown.

Stocks Slide on Global Growth Concerns; Trump Repeats Fed Rate Criticism

Stocks Slide on Global Growth Concerns; Trump Repeats Fed Rate Criticism

Global stocks drifted lower Monday, pushing U.S. equity futures heading into red at the start of what is likely the final full trading week of the year, as investors remain cautious over the health of the world economy and remain focused on two key policy events in the coming days.

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal

Interest in Johnson & Johnson Stock Dries Up Amid Baby Powder Scandal

The market appears to still be spooked by JNJ as shares are set to open at their lowest level since July amid the Reuters articles fallout.

Jim Cramer: Trust This Market? It Remains Treacherous

Jim Cramer: Trust This Market? It Remains Treacherous

Now the unnerving thing about this market is that when it gets on a negative roll it blows through all convention.

Investors No Longer Trust Growth, Plus How to Play JNJ: Market Recon

Investors No Longer Trust Growth, Plus How to Play JNJ: Market Recon

While headline-chasing algorithms alter expected outcomes based on fundamental analysis, technical analysis remains valid.

Goldman Sachs, Oracle, J&J, Nissan and Colin Kroll - 5 Things You Must Know

Goldman Sachs, Oracle, J&J, Nissan and Colin Kroll - 5 Things You Must Know

U.S. stock futures are lower Monday as investors remain cautious over the health of the world economy and look to the Federal Reserve's decision on interest rates Wednesday; officials in Malaysia file criminal charges against Goldman Sachs related to the 1MDB scandal; Nissan's board is meeting Monday to pick a chairman to replace Carlos Ghosn, who was arrested on charges of financial misconduct.

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

It's a brutal market these days, but bargains are being created, Jim Cramer told Mad Money viewers Friday.

Weekly Roundup

It was another volatile week in the U.S. equity markets.

TheStreet Quant Rating: B (Buy)